N80
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All participants: BMI 18-30 kg/m2; hormonal contraception Patients additionally: confirmed diagnosis of endometriosis
Exclusion criteria
Exclusion criteria: Patients: severe acute / organic psychiatric illnesses, neurological or oncological diseases; diabetes mellitus, increased bleeding tendency, regular use of opioids or neuromodulators. Healthy participants: any mental or physical illness, especially pain, urogenital/gynecological symptoms or gastrointestinal symptoms and regular use of medication (except hormonal contraceptives). All participants: MRI-relevant exclusion criteria (e.g. claustrophobia, ferromagnetic implants), evidence of substance abuse; changes in the anorectal area; pregnancy or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Valence and fear ratings of predictive cues assessed using visual analog scales (VAS); electrodermal activity (EDA) as a psychophysiological response. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the valence and intensity of acoustic stimuli and pain stimuli (VAS); state anxiety (questionnaire), salivary concentrations of cortisol and alpha-amylase (neuroendocrine stress markers); analysis of changes in the electrogastrogram signal (EGG), blood pressure and heart rate variability (HRV) (indirect measures of autonomic responses and arousal); cytokines IL-6, IL-8 and TNF-alpha as well as the acute-phase proteins C-reactive protein (CRP) and serum amyloid A (SAA) for the detection of (sub-)clinical inflammation. | — |
Countries
Germany
Contacts
Abteilung für Medizinische Psychologie und Medizinische Soziologie